NIKKEI 225
29,098.24 -7.76 (-0.03%) HANG SENG
25,628.74 -409.56 (-1.57%) GOLD FUTURES
1,797.80 +4.40 (+0.25%) DOW
35,490.69 -266.19 (-0.74%) BTC-GBP
42,906.16 -2,484.10 (-5.47%) CMC Crypto 200
1,406.02 -68.31 (-4.63%)
Titan Medical Inc. (TMDI)
After hours: 04:36PM EDT
| Previous close | 1.7000 |
| Open | 1.7000 |
| Bid | 1.6500 x 1200 |
| Ask | 1.6700 x 1100 |
| Day's range | 1.6500 - 1.7100 |
| 52-week range | 0.6500 - 3.4700 |
| Volume | 175,264 |
| Avg. volume | 396,338 |
| Market cap | 180.721M |
| Beta (5Y monthly) | 4.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4760 |
| Earnings date | 15 Nov 2021 - 19 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Titan Medical Announces Completion of Pre-Clinical GLP Studies
TORONTO, October 25, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed its scheduled pre-clinical studies with its Enos™ robotic single access surgical system, performed in accordance with FDA’s good laboratory practice (GLP) regulations. GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory
- Business Wire
Titan Medical to Participate in Upcoming Investor Conferences in September
TORONTO, September 14, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system and participate in one-on-one investor meetings at two upcoming investor conferences:
- Business Wire
Titan Medical to Participate in H.C. Wainwright Investor Conference
TORONTO, September 07, 2021--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of its innovative surgical technologies for robotic single access surgery, today announced that David McNally, President and CEO of Titan Medical, will present an overview of the company and its Enos™ robotic single access surgical system at the H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021. The presentation w
